ASNO/SNO Joint session in SNO 2022

We successfully held the ASNO/SNO joint session (SNO 2022) in Tampa, Florida. This joint session was first held in 2012 in Washington DC and was continually held as a morning session in SNO annual meetings. However, it was not held over the past two years due to COVID-19. We set “Cell of Origin and Cancer Stem” as the theme this year and selected the best speakers from both ASNO and SNO. Despite the early morning start, there were more than 300 audience members, the largest on record. All speakers provided excellent talks and received many questions from the audience, making for an exciting and fruitful session. We hope to host another great joint session in SNO 2023 Vancouver, Canada on November 15-19.

Scientific committee chair: Mitsutoshi Nakada

Prof. Ohka (right end) is presenting.

From right side. Prof. Lathia, Prof. Parada, Prof. Dirks, Prof. Nakada, Prof. Ohka, and Prof. Kang.

27^th SNO meeting in Tampa 2022, ASNO/SNO Joint session

Friday, November 18, 2022　 7:15 AM – 8:45 AM

Theme: Cell of Origin and Cancer Stem Cells

Co-Chairpersons

Peter Dirks, MD, PhD. Hospital for Sick Children, Toronto, ON, Canada

Mitsutoshi Nakada, MD. PhD. Kanazawa University, Japan

Speakers

	Human Glioblastoma Origin-Cells Discovery in Subventricular Zone, Based on the Glioblastoma Genesis Mechanism of Firework Pattern   Seok-Gu Kang, MD, PhD. Yonsei University, Korea
	Epigenetic Consequences of Genetic Alterations in Cell of Origin for Glioma   Fumiharu Ohka, MD, PhD. Nagoya University, Japan
	Partners in Crime: Tumor Microenvironment Induction and Maintenance of the Stem Cell State in Glioblastoma   Justin D. Lathia, Ph.D. Cleveland Clinic, OH, USA
	Lessons from GBM Patient-Derived Xenographs   Luis F. Parada, Ph.D. Memorial Sloan Kettering Cancer Center, NY, USA